Find your future career

Join Grünenthal

experienced professionals

Stronger together:

Take up the challenge

Young Professionals

Come on board:

Kick start your career

Students

Get experience:

Internships for students

Logo Be!Grünenthal

We research, we develop, we bring true innovations to the marketplace. Is that also your goal? Do you also want to sustainably improve the lives of our patients?

Are you an innovative researcher, an unconventional thinker, a strategist, a visionary, a creative thinker, a pragmatist, or a go-getter? In short, are you a person who will rise to the challenge and make a difference?

Then we look forward to telling you more about Grünenthal—about us, what makes us tick, and how we can reach our goals together - every day, worldwide.

Annette, Communications Management, experienced professionals, Grünenthal, wide range of challenges, contribute to the company’s success

Annette, Communications Management

"There’s a wide range of challenges in an inspiring environment here. It’s great to contribute to the company’s success.”

What drives us and what we do - Stay up to date with all the happenings at Grünenthal

Our news


12 Jun 2018

Grünenthal Initiates Pivotal Phase III Trials in Complex Regional Pain Syndrome

Aachen, Germany, June 12, 2018 – Grünenthal announced today that first patients have been enrolled in two trials of the company’s pivotal phase III program investigating neridronate for the treatment of Complex Regional Pain Syndrome (CRPS). These two trials, KF7013-02 and KF7013-04, are investigating the efficacy and safety of neridronate in 360 patients with CRPS. Neridronate, a bisphosphonate, is an innovative investigational medicine discovered and developed by Abiogen Pharma and now being further developed by Grünenthal for the US territory.

More ...

23 Apr 2018

Dr. Philip Just Larsen Appointed Chief Scientific Officer (CSO)

Aachen, Germany, 23 April 2018 – Grünenthal announced today that Philip Just Larsen has been appointed Chief Scientific Officer (CSO) and Member of the Corporate Executive Board. He will assume leadership of Grünenthal’s research and development organization on 1 July 2018. Currently, Philip holds the role of Global Head of Diabetes Research and Translational Medicine and Chief Scientific Officer at Sanofi’s German Hub in Frankfurt.

More ...

previous [2] next [2]

awards